IntelGenx Announces FDA Approval of RIZAFILM® for the Treatment of Acute Migraine
17 avr. 2023 08h15 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the U.S. Food...
IntelGenx Announces Organizational Changes to Support Global Growth Strategy
13 avr. 2023 09h17 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 13, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced various changes to its management team....
IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Results
29 mars 2023 16h05 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 29, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and...
IntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023
24 mars 2023 16h15 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 24, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that, further to its...
IntelGenx to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 – Conference Call to Follow
23 mars 2023 16h30 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release...
IntelGenx Announces Closing of Notes Offering
21 mars 2023 16h30 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private...
CORRECTION – IntelGenx to Participate in the 35th Annual Roth Conference
09 mars 2023 11h04 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 09, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT), please note that the time...
IntelGenx to Participate in the 35th Annual Roth Conference
09 mars 2023 10h35 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, will be participating...
IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent
21 févr. 2023 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that the United...
IntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm® for the Treatment of Parkinson’s Disease
09 févr. 2023 08h00 HE
|
IntelGenx Technologies Corp.
SAINT-LAURENT, Quebec, Feb. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research...